Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12611000593932
ACTRN12611000593932
Completed
N/A

Patient outcomes after open and minimally invasive surgery for prostate cancer

Mari Botti0 sites450 target enrollmentJune 8, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsocalised Prostate CancerLocalised Prostate CancerCancer - ProstateSurgery - Surgical techniques

Overview

Phase
N/A
Intervention
Not specified
Conditions
ocalised Prostate Cancer
Sponsor
Mari Botti
Enrollment
450
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 8, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
Mari Botti

Eligibility Criteria

Inclusion Criteria

  • •Patients undergoing Radical Retropubic Prostatectomy, Robot Assisted Radical Prostatectomy and Laparascopic Radical Prostatectomy for localised prostate cancer, admitted for elective surgery, over the age of 18 years and under the care of urology surgeons listed as Investigators.

Exclusion Criteria

  • •Patients who are unable to provide informed consent to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
To look for any improvement or decline of a patients status after undergoing surgical removal of thymus by the use of instruments designed to be used through small incisions made on chest.Health Condition 1: G700- Myasthenia gravis
CTRI/2020/06/025612All India Institute of Medical Sciences New Delhi
Completed
N/A
Complications for surgery after COVID 19 infectioHealth Condition 1: O- Medical and Surgical
CTRI/2021/10/037178Dr Sara Vergis140
Completed
N/A
Comparison of surgical outcomes in the treatment of renal stones larger than 1 centimeters between minimally invasive percutaneous nephrolithotomy (MPCNL) and retrograde intrarenal stone surgery (RIRS)Diseases of The genitoruinary system
KCT0001408Seoul Metropolitan Government Seoul National University Boramae Medical Center70
Recruiting
Phase 3
A phase III study of minimally invasive versus open esophagectomy for thoracic esophageal cancer (JCOG1409, MONET trial)clinical stage I/II/III (excluding T4) thoracic esophageal cancer
JPRN-UMIN000017628Japan Clinical Oncology Group (JCOG)300
Recruiting
N/A
ong-term outcome of minimally invasive treatment of Early Gastric Cancer beyond Endoscopic Submucosal DissectioNeoplasms
KCT0001823Bundang CHA General Hospital48